Trade Summary

5 days ago, Steik Jason Paul, serving as Chief Clinical Officer at Pennant Group, Inc. (PNTG), sold 1,394 shares at $38.52 per share, for a total transaction value of $53,699.67. Following this transaction, Steik Jason Paul now holds 15,106 shares of PNTG.

This sale represents a 8.45% decrease in Steik Jason Paul's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 3:48 PM ET, 4 days after the trade was made.

Pennant Group, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL CARE FACILITIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.